Byonyks
M. Salahuddin Khan serves as the Chief Technology Officer at Byonyks, a medical devices company, since January 2022, following a tenure as VP of Advanced Engineering at the same company. In addition to this role, Khan has been the VP Technology at Delphi Sales Consulting, LLC since May 2014, contributing to pharmaceutical sales growth strategies. An award-winning author, Khan published the novel "Sikander" through KARAKORAM PRESS, which details the journey of a Pakistani youth. As the founder of QMarket Corporation from September 2011 to December 2016, Khan specialized in growth strategy development across various industries. Other notable positions include co-founder of Lifeline Holdings, Executive Director at Human Development Foundation, and multiple roles at NAVTEQ, where strategic initiatives significantly increased the company's market value. An educational background includes a BSc Hons in Aeronautics & Astronautics from the University of Southampton.
This person is not in any teams
This person is not in any offices
Byonyks
Byonyks has pioneered the world’s first affordable Bloodless Dialysis machine, transforming care for kidney failure patients. Globally, over eight million people with kidney disease lack dialysis access—a costly, invasive, and time-consuming treatment that filters blood when kidneys fail. Many of these individuals face life-threatening consequences due to the lack of proper care. Byonyks addresses this critical issue with its Bloodless Dialysis machine; a safe, effective, portable, and non-invasive solution that’s more affordable than existing options. Our technology empowers patients to perform dialysis at home, overnight, while they sleep, allowing them to maintain their daily work and family responsibilities. The needle-free approach also reduces the risk of chronic infections such as HIV and Hepatitis C. Headquartered in the USA and South Asia, Byonyks is a medical device startup founded by Harvard/MIT graduates and industry experts. Our core team’s expertise contributes to over half of the operational peritoneal dialysis machines worldwide. The groundbreaking Bloodless Dialysis machine has saved multiple lives in South Asia and is currently under FDA review—a pivotal step towards making accessible kidney care a global reality.